Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: A nation-wide, population-based register study

Acta Paediatrica, International Journal of Paediatrics

Volumn 93, Issue 2, 2004, Pages 174-176

  Wide, K ^a   Winbladh, B ^b   Kallen B ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SACHS CHILDREN S HOSPITAL   (Sweden)

^c UNIVERSITY OF LUND   (Sweden)

Author keywords

Antiepileptic drugs; Folic acid; Major congenital malformations; Pregnancy; Valproic acid

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; ETHOSUXIMIDE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ANTICONVULSANT THERAPY; ARTICLE; CLEFT LIP FACE PALATE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CRANIOFACIAL SYNOSTOSIS; DIAPHRAGM HERNIA; DRUG EFFECT; EPILEPSY; ESOPHAGUS ATRESIA; GASTROINTESTINAL DISEASE; HEART DISEASE; HUMAN; HYPOSPADIAS; INFANT; INFANT DISEASE; INTESTINE ATRESIA; MAJOR CLINICAL STUDY; MONOTHERAPY; NEURAL TUBE DEFECT; OUTCOMES RESEARCH; POPULATION RESEARCH; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; REGISTER; RISK ASSESSMENT; RISK FACTOR; TERATOGENESIS;

ABNORMALITIES, MULTIPLE; ADULT; ANTICONVULSANTS; CARBAMAZEPINE; EPILEPSY; FEMALE; FETAL DISEASES; HUMANS; INFANT, NEWBORN; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PRENATAL EXPOSURE DELAYED EFFECTS; REGISTRIES; VALPROIC ACID;

EID: 1242314854     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035250310021118     Document Type: Article

References (16)

1. Källén B, Robert E, Mastroiacovo P, Martínez- Frías ML, Castilla EE, Cocchi G. Antiepileptic drugs and malformations. Is there a drug specificity? Eur J Epidemiol 1989; 5: 31-6
2. Samrén EB, van Duijn CM, Christiaens GC, Hofman A, Lindhout D. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 1999; 46: 739-46
3. Canger R, Battino D, Canevini MP, et al. Malformations in offspring of women with epilepsy. A prospective study. Epilepsia 1999; 40: 1231-6
4. Arpino C, Brescianini S, Robert E, et al. Teratogenic effect of antiepileptic drugs; use of an international database on malformations and drug exposure. Epilepsia 2000; 41: 1436-43
5. Arpino C, Brescianini S, Robert E, et al. Teratogenic effect of antiepileptic drugs; use of an international database on malformations and drug exposure. Epilepsia 2000; 41: 1436-43
6. Cnattingius S, Ericson A, Gunnarskog J, Källén B. A quality study of a medical birth registry. Scand J Soc Med 1990; 18: 143-8
7. Källén B. Search for teratogenic risks with the aid of malformation registries. Teratology 1987; 35: 47-52
8. Samrén EB, van Duijn CM, Koch S, et al. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 1997; 38: 981-90
9. Kaneko S, Battino D, Andermann E, et al. Congenital malformations due to antiepileptic drugs. Epilepsy Res 1999; 33: 145-58
10. Robert E, Guibaud P. Maternal valproic acid and congenital neural tube defects. Lancet 1982; ii: 937
11. Lindhout D, Meinardi H. Spina bifida in utero exposure to valproate. Lancet 1984; ii: 396
12. Lammer EJ, Sever LE, Oakley GP, Jr. Teratogen update: valproic acid. Teratology 1987; 35: 465-73
13. Battino D, Binelli S, Caccamo ML, et al. Malformations in offspring of 305 epileptic women: a prospective study. Acta Neurol Scand 1992; 85: 204-7
14. Lindhout D, Omtzigt J, Cornel M. Spectrum of neural-tube defects in 34 infants prenatally exposed to antiepileptic drugs. Neurology 1992; 42 Suppl 5: 111-8
15. Rosa FW. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 1991; 324: 674-7
16. Källén B. Maternal carbamazepine and infant spina bifida. Reprod Toxicol 1994; 8: 203-5